← All organizations
Highest phase reached
Phase 3
First clinical trial
Apr 30, 2019Last known activity
Dec 13, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (7 distinct, 2 trials)
Phase 3 (6 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (2)
- NCT06282588Lead sponsorPhase 2/Phase 3Dec 13, 2023
- NCT03899077Lead sponsorPhase 2Apr 30, 2019
Details
- Last known activity
- Dec 13, 2023